1. Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Studies of Indole Based Thiadiazole Derivatives as Dual Inhibitor of Acetylcholinesterase and Butyrylchloinesterase
- Author
-
Shoaib Khan, Shahid Iqbal, Muhammad Taha, Fazal Rahim, Mazloom Shah, Hayat Ullah, Ali Bahadur, Hamad Alrbyawi, Ayed A. Dera, Mohammed Issa Alahmdi, Rami Adel Pashameah, Eman Alzahrani, and Abd-ElAziem Farouk
- Subjects
Indoles ,Molecular Structure ,Organic Chemistry ,Pharmaceutical Science ,Analytical Chemistry ,Molecular Docking Simulation ,Structure-Activity Relationship ,Chemistry (miscellaneous) ,Thiadiazoles ,Drug Discovery ,Acetylcholinesterase ,Molecular Medicine ,Cholinesterase Inhibitors ,indole ,thiadiazole analogs ,SAR ,AchE and BuChE inhibitors ,molecular docking ,Physical and Theoretical Chemistry - Abstract
The current study was conducted to obtain hybrid analogues of indole-based thiadiazole derivatives (1–16) in which a number of reaction steps were involved. To examine their biological activity in the presence of the reference drug Donepezil (0.21 ± 0.12 and 0.30 ± 0.32 M, respectively), the inhibitory potentials of AChE and BuChE were determined for these compounds. Different substituted derivatives showing a varied range of inhibitory profiles, when compared to the reference drug, analogue 8 was shown to have potent activity, with IC50 values for AchE 0.15 ± 0.050 M and BuChE 0.20 ± 0.10, respectively, while other substituted compounds displayed good to moderate potentials. Varied spectroscopic techniques including 1H, 13CNMR and HREI-MS were used to identify the basic skeleton of these compounds. Furthermore, all analogues have a known structure–activity relationship (SAR), and molecular docking investigations have verified the binding interactions of molecule to the active site of enzymes.
- Published
- 2022
- Full Text
- View/download PDF